Several mouse models of obesity also revealed beneficial effects of IL-22 treatment on glucose homeostasis, insulin sensitivity, insulin secretion and inflammation [4, 5]. The gene discussed is IL22; the disease is obesity due to melanocortin 4 receptor deficiency.